From anti-aging drugs to cancer therapy: is there a potential for sirtuin activators in gliomas?
Neuro Oncol
.
2021 Jan 30;23(1):3-5.
doi: 10.1093/neuonc/noaa234.
Authors
Christiane A Opitz
1
,
Sevin Turcan
1
2
Affiliations
1
German Cancer Consortium Brain Cancer Metabolism Group, German Cancer Research Center, Heidelberg, Germany.
2
Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
PMID:
33059365
PMCID:
PMC7849941
DOI:
10.1093/neuonc/noaa234
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Aging
Glioma* / drug therapy
Humans
Pharmaceutical Preparations*
Sirtuins*
Substances
Pharmaceutical Preparations
Sirtuins